October 17, 2017 Informatics & Software Life Science Tools

Intermountain Healthcare Announces Precision Health Research Endeavors With 10x Genomics

– Linked-Reads will be used to advance precision health and personalized medicine – PLEASANTON, CA and SAINT GEORGE, UT –Intermountain Precision Genomics and 10x Genomics announced today, the addition of Chromium™ Genome Solution to the Translational Science Center (TSC). The center currently houses several of the latest high-throughput next-generation sequencing instruments for large-scale whole genome... Read more

October 17, 2017 Lab Top-10 Life Science Tools Product Launch

Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research

New CRISPR-based Transcriptional Activation and Interference (a/i) Libraries SANTA CLARA, Calif., October 17, 2017 Agilent Technologies Inc. (NYSE: A) today announced the first expansion of the SureGuide pooled CRISPR libraries for functional genomics, offering pooled libraries for CRISPR activation and interference (CRISPR a/i). The announcement was made at the at the American Society for Human... Read more

October 17, 2017 Clinical Research/Diagn. Informatics & Software M&A, Partnerships

The Jackson Laboratory and Seven Bridges Collaborate to Build Centralized Data Platform to Advance Cancer Research

October 17, 2017 National Cancer Institute awards $2M grant to fund joint PDX data center to integrate, share, and analyze cancer treatment data for research community FARMINGTON, Conn., and BOSTON, Mass., October 17, 2017 – The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to... Read more

October 17, 2017 M&A, Partnerships Materials Analysis

ZEISS signed strategic partnership agreement with Xnovo

JENA/Germany, KØGE/Denmark, 2017-10-17. The ZEISS Microscopy business group announced today that it has signed an exclusive strategic partnership agreement with Denmark-based Xnovo Technology ApS, a company that develops innovative software-based 3D X-ray imaging and analysis solutions. The two companies have already been working together over the past two years. This strategic partnership is targeting to... Read more

October 17, 2017 Life Science Tools

Oxford Nanopore starts developer programme to trial new enrichment methods for real time nanopore sequencing

Tue 17th October 2017 Oxford Nanopore is developing target enrichment processes for the nanopore sequencing platform, based on the CRISPR/Cas9 system. When coupled with real-time nanopore DNA analysis, these techniques are designed to help users target and resolve specific biological questions more quickly and efficiently than possible with whole genome sequencing. The first participants are... Read more

October 17, 2017 Life Science Tools

WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data

– Long-read, real-time DNA and RNA sequencing now available to researchers and clinical scientists through China’s preeminent and most comprehensive CLIA/CAP laboratory – WuXi NextCODE partners can now combine nanopore sequencing and the world’s leading informatics to solve genomics challenges with the potential to improve health SHANGHAI, CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Oct. 17, 2017 /PRNewswire/ — WuXi NextCODE,... Read more

October 13, 2017 Microscopy

ZEISS Invests over EUR 300 Million in Jena High-Tech Site

ZEISS continues its strategic, global investment and growth trajectory New integrated high-tech site, which will benefit the entire region and bring together all local ZEISS units by 2023 Founding site of Jena to remain one of the top innovation hubs for ZEISS Plans to forge closer links to science, teaching and local industry The state... Read more

October 13, 2017 Cell Analysis Tools PR/Corporate

BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock

ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 13, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced the pricing of an underwritten public offering of 9,615,385 shares of its common stock at a public offering price of $2.60 per share. The gross proceeds to BioTime from this offering... Read more

October 13, 2017 PR/Corporate

Honeywell Names Brian S. Cook Global Head of M&A

October 13, 2017 MORRIS PLAINS, N.J., Oct. 13, 2017 /PRNewswire/ — Honeywell (NYSE: HON) today named Brian S. Cook as Vice President of Corporate Development and Global Head of Mergers & Acquisitions, reporting to Senior Vice President and CFO Thomas A. Szlosek. Cook succeeds Anne Madden, who was recently named as Honeywell’s Senior Vice President and General Counsel. “Brian has been responsible for... Read more